An epigenetic blueprint reveals how aggressive MYC amplification fuels cancer

Researchers at the Cancer Epigenetics Institute (CEI) at Fox Chase Cancer Center have discovered how to control and stop the amplification of MYC—one of the most commonly altered cancer genes linked to aggressive tumor growth and treatment resistance.